Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366775314> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4366775314 endingPage "117" @default.
- W4366775314 startingPage "111" @default.
- W4366775314 abstract "The immortal phenotype of cancer cells is a significant trait, and in the vast majority of malignancies, the enzyme telomerase is essential for sustaining the cancer cells' limitless capacity for replication. The absence of telomerase expression and the lack of an immortal phenotype in normal adult tissues suggest that telomerase is a prospective therapeutic target for the treatment of a variety of tumor forms. At every cell division, telomeres will shrink if telomerase is not active. Apoptosis, cell senescence, and chromosomal instability are initiated when the telomeres become critically short. Telomeres are stabilized in the majority of rapidly expanding cancers by reactivating telomerase. In numerous tumor forms, it has been demonstrated that telomerase inhibition inhibits the development of cancer cells. Telomerase inhibitors have been discovered over the past 10 years as a result of substantial basic research into the mechanisms regulating telomeres, which may offer a potent, nearly universal cancer treatment approach. A short-chain oligonucleotide called imetelstat [GRN163L, Geron Corporation] has a high affinity and specificity for the RNA component of telomerase's template region [hTR or hTERC]. Researchers conduct an examination of articles that are in accordance with the issue to be studied. Articles used in literature review are obtained through the database of international journal providers through PubMed, we investigated clinical studies and discussed what happened in these clinical studies and the extent of the effectiveness of imetelstat in treatment of cancer. Articles proved that imetelstat could enhance cancer treatment. Articles proved that Imetelstat is promising therapeutic agents for cancer treatment. In this review, we suggest that formulating and following treatment, Further studies are needed to determine the related mechanisms to enhance Imetelstat efficacy." @default.
- W4366775314 created "2023-04-25" @default.
- W4366775314 creator A5015604877 @default.
- W4366775314 creator A5069230476 @default.
- W4366775314 creator A5076960090 @default.
- W4366775314 date "2023-04-21" @default.
- W4366775314 modified "2023-09-25" @default.
- W4366775314 title "Therapeutic impact of Telomerase Inhibitor Imetelstat: A Literature Review" @default.
- W4366775314 doi "https://doi.org/10.35882/ijahst.v3i2.238" @default.
- W4366775314 hasPublicationYear "2023" @default.
- W4366775314 type Work @default.
- W4366775314 citedByCount "0" @default.
- W4366775314 crossrefType "journal-article" @default.
- W4366775314 hasAuthorship W4366775314A5015604877 @default.
- W4366775314 hasAuthorship W4366775314A5069230476 @default.
- W4366775314 hasAuthorship W4366775314A5076960090 @default.
- W4366775314 hasBestOaLocation W43667753141 @default.
- W4366775314 hasConcept C104317684 @default.
- W4366775314 hasConcept C121608353 @default.
- W4366775314 hasConcept C125593758 @default.
- W4366775314 hasConcept C177336024 @default.
- W4366775314 hasConcept C502942594 @default.
- W4366775314 hasConcept C54355233 @default.
- W4366775314 hasConcept C552990157 @default.
- W4366775314 hasConcept C86803240 @default.
- W4366775314 hasConcept C94581717 @default.
- W4366775314 hasConcept C96232424 @default.
- W4366775314 hasConceptScore W4366775314C104317684 @default.
- W4366775314 hasConceptScore W4366775314C121608353 @default.
- W4366775314 hasConceptScore W4366775314C125593758 @default.
- W4366775314 hasConceptScore W4366775314C177336024 @default.
- W4366775314 hasConceptScore W4366775314C502942594 @default.
- W4366775314 hasConceptScore W4366775314C54355233 @default.
- W4366775314 hasConceptScore W4366775314C552990157 @default.
- W4366775314 hasConceptScore W4366775314C86803240 @default.
- W4366775314 hasConceptScore W4366775314C94581717 @default.
- W4366775314 hasConceptScore W4366775314C96232424 @default.
- W4366775314 hasIssue "2" @default.
- W4366775314 hasLocation W43667753141 @default.
- W4366775314 hasOpenAccess W4366775314 @default.
- W4366775314 hasPrimaryLocation W43667753141 @default.
- W4366775314 hasRelatedWork W1972393066 @default.
- W4366775314 hasRelatedWork W2005146652 @default.
- W4366775314 hasRelatedWork W2055434593 @default.
- W4366775314 hasRelatedWork W2069082021 @default.
- W4366775314 hasRelatedWork W2151468358 @default.
- W4366775314 hasRelatedWork W2333767761 @default.
- W4366775314 hasRelatedWork W2415713579 @default.
- W4366775314 hasRelatedWork W2424105038 @default.
- W4366775314 hasRelatedWork W3122261276 @default.
- W4366775314 hasRelatedWork W4285085774 @default.
- W4366775314 hasVolume "3" @default.
- W4366775314 isParatext "false" @default.
- W4366775314 isRetracted "false" @default.
- W4366775314 workType "article" @default.